Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Delta-9-THC and Delta-8-THC on Driving Performance
NCT06236815Phase 1Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial comparing Delta-9-THC, Delta-8-THC and Placebo (3 arms). Primary endpoints: Quantify analyte concentrations at 9 months and Quantify impairing effects of cannabinoids at 9 months. Started Jan 2025; status: completed.
02
Drugs
dronabinoldelta-8-tetrahydrocannabinol
Beyond the preview
Go deeper on NCT06236815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06236815.